SAVITZ RYAN (EVP, CFO & CBO) sold 8.22K shares of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $738.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/10/2026ACC: 0001992324-26-000006
Officer· EVP, CFO & CBO
Since Feb 2026
-8.22K
Net shares
Net seller
$738.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.22K acquired · 16.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.22K
Price / share
$17.88
Trade value
$147.05K
% of position
New position
4/9/2026
0.00→8.22K
Common Stock
Direct
Shares
−8.22K
Price / share
$89.84
Trade value
$738.84K
% of position
New position
4/9/2026
8.22K→0.00
Total
Net shares
+0.00
Net value
-$591.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/9/2026 | M · Option Exercise | +8.22K | $17.88 | $147.05K | New position | 0.00 | 8.22K |
| Common Stock Direct | 4/9/2026 | S · Sale | −8.22K | $89.84 | $738.84K | New position | 8.22K | 0.00 |
| Total | +0.00 | -$591.80K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.22K shares
Shares
−8.22K
Strike price
17.88
Held after
71.78K
Exercisable
—
4/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8.22K shares | 4/9/2026 | M · Option Exercise | −8.22K | 17.88 | — | 71.78K |